Penumbra Inc. (PEN)
BMV
Closed
Aug 21, 2026
Day's Range
4,775.7052 wk Range
4,775.70Overview - PEN - Penumbra Inc.
Key Statistics
Valuation
Enterprise Value
3.17T
P/E (Trailing)
‪62.11‬
PEG Ratio
‪-2.64‬
Price / Sales (TTM)
‪125.00‬
Price / Book
‪7.24‬
EV / EBITDA
‪918.66‬
Profitability
Gross Margin
‪67.92%‬
Profit Margin
‪10.67%‬
Operating Margin
‪10.52%‬
Return on Assets
‪6.41%‬
Return on Equity
‪11.37%‬
Ownership
Shares Outstanding
39.38M
Float
38.27M
Held by Insiders
‪2.90%‬
Held by Institutions
‪88.31%‬
Price stats
Beta
‪0.70‬
50-Day Avg
‪4,775.70‬
200-Day Avg
‪4,775.70‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - PEN - Penumbra Inc.
Peers - PEN - Penumbra Inc.
Peer Comparison
Compared with companies in Medical Devices listed on BMV.
Profile Summary - PEN - Penumbra Inc.
About
Penumbra Inc., a healthcare company, is dedicated to the design, development, and manufacturing of innovative medical devices. Specializing primarily in the treatment of vascular and neurovascular conditions, its products are instrumental in aiding procedures that address stroke, aneurysms, and peripheral arterial…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
